市場調査レポート

商品コード

1402889

経肺ドラッグデリバリーデバイス市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2023年11月24日 | 発行: Transparency Market Research

| ページ情報: 英文 170 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 908,424円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,378,704円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,848,984円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

経肺ドラッグデリバリーデバイス市場- レポートの範囲

世界の経肺ドラッグデリバリーデバイス市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、2023年を基準年、2031年を予測年とみなし、2017年から2031年の期間の世界の経肺ドラッグデリバリーデバイス市場の収益を提供します。このレポートは、2023年から2031年までの世界の経肺ドラッグデリバリーデバイス市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、経肺ドラッグデリバリーデバイス市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値	372億米ドル
2031年の市場価値	550億米ドル
CAGR	4.4%

このレポートは、世界の経肺ドラッグデリバリーデバイス市場の競合情勢を詳しく調査しています。世界の経肺ドラッグデリバリーデバイス市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の経肺ドラッグデリバリーデバイス市場のプレーヤーの属性です。

List of Tables

Table 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 02: Global Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 03: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 04: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 05: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2023-2031
Table 06: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2023-2031
Table 07: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 08: North America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 09: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 11: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 12: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 13: Europe Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 14: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 15: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
Table 16: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 17: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 18: Asia Pacific Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 19: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 20: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 21: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 22: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 23: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 24: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 25: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
Table 26: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 27: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 28: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 29: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 30: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031

List of Figures

Figure 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 02: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 03: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 04: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 05: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 06: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 07: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 08: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2022 and 2031
Figure 09: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region, 2023-2031
Figure 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 11: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 12: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 13: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 14: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 15: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 16: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 17: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2022 and 2031
Figure 18: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country, 2023-2031
Figure 19: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 20: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 21: Europe America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 22: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 23: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 24: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 25: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 26: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 27: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 28: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 29: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 30: Asia Pacific America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 31: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 32: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 33: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 34: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 35: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 37: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 38: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 39: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 40: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 41: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
Figure 42: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 43: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 44: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 46: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
Figure 47: Middle East & Africa America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023-2031
Figure 48: Middle East & Africa America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 49: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 50: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 51: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 52: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 53: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2022)

Product Code: TMRGL48993

Pulmonary Drug Delivery Devices Market - Scope of Report

TMR's report on the global pulmonary drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global pulmonary drug delivery devices market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pulmonary drug delivery devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pulmonary drug delivery devices market.

Market Snapshot
Market Value in 2023	US$ 37.2 Bn
Market Value in 2031	US$ 55 Bn
CAGR	4.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pulmonary drug delivery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pulmonary drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pulmonary drug delivery devices market.

The report delves into the competitive landscape of the global pulmonary drug delivery devices market. Key players operating in the global pulmonary drug delivery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pulmonary drug delivery devices market profiled in this report.

Key Questions Answered in Global pulmonary drug delivery devices Market Report:

What is the sales/revenue generated by pulmonary drug delivery devices across all regions during the forecast period?
What are the opportunities in the global pulmonary drug delivery devices market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Pulmonary Drug Delivery Devices Market - Research Objectives and Research Approach

The comprehensive report on the global pulmonary drug delivery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pulmonary drug delivery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pulmonary drug delivery devices market.

1. Executive Summary

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pulmonary Drug Delivery Devices Market

4. Market Overview

4.1. Market Segmentation
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, 2023-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. COVID-19 Pandemic Impact on Industry

6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type

6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value & Volume Forecast, by Product Type, 2023-2031
- 6.3.1. Dry Powder Inhalers
- 6.3.2. Metered Dose Inhalers
- 6.3.3. Nebulizers
6.4. Market Attractiveness, by Product Type

7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application

7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value & Volume Forecast, by Application, 2023-2031
- 7.3.1. Asthma
- 7.3.2. COPD
- 7.3.3. Cystic Fibrosis
- 7.3.4. Others
7.4. Market Attractiveness, by Application

8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel

8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
- 8.3.1. Retail Pharmacies
- 8.3.2. Hospital Pharmacies
- 8.3.3. E-Commerce
8.4. Market Attractiveness, by Distribution Channel

9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region, 2023-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region

10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2023-2031
- 10.2.1. Dry Powder Inhalers
- 10.2.2. Metered Dose Inhalers
- 10.2.3. Nebulizers
10.3. Market Attractiveness, by Product Type
10.4. Market Value & Volume Forecast, by Application, 2023-2031
- 10.4.1. Asthma
- 10.4.2. COPD
- 10.4.3. Cystic Fibrosis
- 10.4.4. Others
10.5. Market Attractiveness, by Application
10.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
- 10.6.1. Retail Pharmacies
- 10.6.2. Hospital Pharmacies
- 10.6.3. E-Commerce
10.7. Market Attractiveness, by Distribution Channel
10.8. Market Value & Volume Forecast, by Country, 2023-2031
- 10.8.1. U.S.
- 10.8.2. Canada
10.9. Market Attractiveness Analysis
- 10.9.1. By Product Type
- 10.9.2. By Application
- 10.9.3. By Distribution Channel
- 10.9.4. By Country

11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2023-2031
- 11.2.1. Dry Powder Inhalers
- 11.2.2. Metered Dose Inhalers
- 11.2.3. Nebulizers
11.3. Market Attractiveness, by Product Type
11.4. Market Value & Volume Forecast, by Application, 2023-2031
- 11.4.1. Asthma
- 11.4.2. COPD
- 11.4.3. Cystic Fibrosis
- 11.4.4. Others
11.5. Market Attractiveness, by Application
11.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
- 11.6.1. Retail Pharmacies
- 11.6.2. Hospital Pharmacies
- 11.6.3. E-Commerce
11.7. Market Attractiveness, by Distribution Channel
11.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
- 11.8.1. Germany
- 11.8.2. U.K.
- 11.8.3. France
- 11.8.4. Italy
- 11.8.5. Spain
- 11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
- 11.9.1. By Product Type
- 11.9.2. By Application
- 11.9.3. By Distribution Channel
- 11.9.4. By Country/Sub-region

12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2023-2031
- 12.2.1. Dry Powder Inhalers
- 12.2.2. Metered Dose Inhalers
- 12.2.3. Nebulizers
12.3. Market Attractiveness, by Product Type
12.4. Market Value & Volume Forecast, by Application, 2023-2031
- 12.4.1. Asthma
- 12.4.2. COPD
- 12.4.3. Cystic Fibrosis
- 12.4.4. Others
12.5. Market Attractiveness, by Application
12.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
- 12.6.1. Retail Pharmacies
- 12.6.2. Hospital Pharmacies
- 12.6.3. E-Commerce
12.7. Market Attractiveness, by Distribution Channel
12.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
- 12.8.1. China
- 12.8.2. Japan
- 12.8.3. India
- 12.8.4. Australia & New Zealand
- 12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
- 12.9.1. By Product Type
- 12.9.2. By Application
- 12.9.3. By Distribution Channel
- 12.9.4. By Country/Sub-region

13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2023-2031
- 13.2.1. Dry Powder Inhalers
- 13.2.2. Metered Dose Inhalers
- 13.2.3. Nebulizers
13.3. Market Attractiveness, by Product Type
13.4. Market Value & Volume Forecast, by Application, 2023-2031
- 13.4.1. Asthma
- 13.4.2. COPD
- 13.4.3. Cystic Fibrosis
- 13.4.4. Others
13.5. Market Attractiveness, by Application
13.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
- 13.6.1. Retail Pharmacies
- 13.6.2. Hospital Pharmacies
- 13.6.3. E-Commerce
13.7. Market Attractiveness, by Distribution Channel
13.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
- 13.8.1. Brazil
- 13.8.2. Mexico
- 13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
- 13.9.1. By Product Type
- 13.9.2. By Application
- 13.9.3. By Distribution Channel
- 13.9.4. By Country/Sub-region

14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product Type, 2023-2031
- 14.2.1. Dry Powder Inhalers
- 14.2.2. Metered Dose Inhalers
- 14.2.3. Nebulizers
14.3. Market Attractiveness, by Product Type
14.4. Market Value & Volume Forecast, by Application, 2023-2031
- 14.4.1. Asthma
- 14.4.2. COPD
- 14.4.3. Cystic Fibrosis
- 14.4.4. Others
14.5. Market Attractiveness, by Application
14.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
- 14.6.1. Retail Pharmacies
- 14.6.2. Hospital Pharmacies
- 14.6.3. E-Commerce
14.7. Market Attractiveness, by Distribution Channel
14.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
- 14.8.1. GCC Countries
- 14.8.2. South Africa
- 14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
- 14.9.1. By Product Type
- 14.9.2. By Application
- 14.9.3. By Distribution Channel
- 14.9.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
- 15.3.1. AstraZeneca Plc
  - 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.1.2. Product Type Portfolio
  - 15.3.1.3. Financial Overview
  - 15.3.1.4. SWOT Analysis
  - 15.3.1.5. Strategic Overview
- 15.3.2. Novartis AG
  - 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.2.2. Product Type Portfolio
  - 15.3.2.3. Financial Overview
  - 15.3.2.4. SWOT Analysis
  - 15.3.2.5. Strategic Overview
- 15.3.3. Boehringer Ingelheim GmbH
  - 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.3.2. Product Type Portfolio
  - 15.3.3.3. Financial Overview
  - 15.3.3.4. SWOT Analysis
  - 15.3.3.5. Strategic Overview
- 15.3.4. GlaxoSmithKline Plc
  - 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.4.2. Product Type Portfolio
  - 15.3.4.3. Financial Overview
  - 15.3.4.4. SWOT Analysis
  - 15.3.4.5. Strategic Overview
- 15.3.5. Merck & Co., Inc.
  - 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.5.2. Product Type Portfolio
  - 15.3.5.3. Financial Overview
  - 15.3.5.4. SWOT Analysis
  - 15.3.5.5. Strategic Overview
- 15.3.6. Teva Pharmaceutical Industries Ltd.
  - 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.6.2. Product Type Portfolio
  - 15.3.6.3. Financial Overview
  - 15.3.6.4. SWOT Analysis
  - 15.3.6.5. Strategic Overview

経肺ドラッグデリバリーデバイス市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

経肺ドラッグデリバリーデバイス市場- レポートの範囲

目次

第1章エグゼクティブサマリー

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章市場分析と予測：製品タイプ別

第7章市場分析と予測：用途別

第8章世界市場の分析と予測：流通チャネル別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東・アフリカ市場の分析と予測

第15章競合情勢

List of Tables

List of Figures

Pulmonary Drug Delivery Devices Market - Scope of Report

Key Questions Answered in Global pulmonary drug delivery devices Market Report:

Pulmonary Drug Delivery Devices Market - Research Objectives and Research Approach

Table of Contents

1. Executive Summary

2. Assumptions and Research Methodology

3. Executive Summary: Global Pulmonary Drug Delivery Devices Market

4. Market Overview

5. Key Insights

6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type

7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application

8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel

9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region

10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast

11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast

12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast

13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast

14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast

15. Competition Landscape

経肺ドラッグデリバリーデバイス市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

経肺ドラッグデリバリーデバイス市場- レポートの範囲

目次

第1章 エグゼクティブサマリー

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

第5章 重要な洞察

第6章 市場分析と予測：製品タイプ別

第7章 市場分析と予測：用途別

第8章 世界市場の分析と予測：流通チャネル別

第9章 世界市場の分析と予測：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

List of Tables

List of Figures

Pulmonary Drug Delivery Devices Market - Scope of Report

Key Questions Answered in Global pulmonary drug delivery devices Market Report:

Pulmonary Drug Delivery Devices Market - Research Objectives and Research Approach

Table of Contents

1. Executive Summary

2. Assumptions and Research Methodology

3. Executive Summary: Global Pulmonary Drug Delivery Devices Market

4. Market Overview

5. Key Insights

6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type

7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application

8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel

9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region

10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast

11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast

12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast

13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast

14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast

15. Competition Landscape

第1章エグゼクティブサマリー

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章市場分析と予測：製品タイプ別

第7章市場分析と予測：用途別

第8章世界市場の分析と予測：流通チャネル別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東・アフリカ市場の分析と予測

第15章競合情勢